Oncology Pharma Inc. (OTCMKTS:ONPH – Get Rating) was the target of a large growth in short interest in January. As of January 31st, there was short interest totalling 30,400 shares, a growth of 28.8% from the January 15th total of 23,600 shares. Based on an average daily trading volume, of 89,400 shares, the short-interest ratio is presently 0.3 days.

Oncology Pharma Price Performance

Shares of ONPH remained flat at $0.38 during midday trading on Tuesday. 20,468 shares of the company's stock traded hands, compared to its average volume of 58,937. The firm has a 50 day simple moving average of $0.44 and a 200 day simple moving average of $0.72. Oncology Pharma has a twelve month low of $0.32 and a twelve month high of $7.23.

About Oncology Pharma

(Get Rating)

Oncology Pharma, Inc engages in the development, manufacture and commercialization of therapeutics. The company was founded by Marcel van Heesewijk on March 26, 1993 and is headquartered in San Francisco, CA.

Featured Stories

• Get a free copy of the StockNews.com research report on Oncology Pharma (ONPH)
• LCI Industries Diversification Strategy Pays Off
• Is It Time To Buy The Dip In The Coca-Cola Company
• Ex-Dividend Date vs. Record Date: What's the Difference?
• How Does the Consumer Price Index Affect the Stock Market?
• Are Denny's Corporation Investors Due For A Grand Slam?

Receive News & Ratings for Oncology Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncology Pharma and related companies with MarketBeat.com's FREE daily email newsletter.